You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer
|
---|---|
Published in |
Investigational New Drugs, October 2014
|
DOI | 10.1007/s10637-014-0175-5 |
Pubmed ID | |
Authors |
Alberta Bergamo, Tina Riedel, Paul J. Dyson, Gianni Sava |
Mendeley readers
The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 34 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 24% |
Student > Master | 5 | 15% |
Professor > Associate Professor | 4 | 12% |
Student > Bachelor | 2 | 6% |
Student > Ph. D. Student | 2 | 6% |
Other | 3 | 9% |
Unknown | 10 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 9 | 26% |
Medicine and Dentistry | 5 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 12% |
Agricultural and Biological Sciences | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Other | 1 | 3% |
Unknown | 12 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2016.
All research outputs
#7,531,132
of 22,979,862 outputs
Outputs from Investigational New Drugs
#327
of 1,173 outputs
Outputs of similar age
#85,526
of 261,131 outputs
Outputs of similar age from Investigational New Drugs
#5
of 17 outputs
Altmetric has tracked 22,979,862 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,173 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 261,131 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.